Role of Intranasal Midazolam As a Procedural Sedative in Children Aged 6 Months to 12 Years: An Open-Label Randomized Controlled Study. Indian J Child Health 2018, 5 (1), 1-5. https://doi.org/10.32677/IJCH.2018.v05.i01.001.